M21 Hyperglycemia Management in the Inpatient Setting

Program: Meet-the-Professor Sessions
Clinical Session
Saturday, April 2, 2016: 10:00 AM-10:45 AM
Room 157 (BCEC)
Saturday, April 2, 2016: 2:15 PM-3:00 PM
Room 157 (BCEC)
Speaker:
Cecilia C. Low Wang, MD, University of Colorado School of Medicine, Aurora, CO

Disclosures:
CCL: Other activities, please specify:, Novo Nordisk, Other activities, please specify:, CSL Behring, Other activities, please specify:, Biogen, Other activities, please specify:, Baxter, Other activities, please specify:, Astra Zeneca, Other activities, please specify:, Osiris, Speaker, Medical Education Resources.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire